Delivery Order SPE2DB25D3017-SPE2DB26FVGSC
- Not listed
- The Defense Logistics Agency awarded a $1,281.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packaging (6-count). The contract is non-set-aside and competitively awarded, with a completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which falls...
- This delivery order, awarded August 8, 2025, by the Defense Logistics Agency's Medical Supply Chain, procures Zolmitriptan 2.5 mg oral disintegrating tablets (unit dose, 6-count packages) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The firm fixed price delivery order, valued at $1,334.50, is scheduled for completion by August 11, 2025, with performance occurring at the vendor's Conshohocken facility. The award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $3,976.38 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg orally disintegrating tablets (ODT) in unit doses of three tablets per package. This contract represents a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The award was issued on September 22, 2025, with an ultimate completion date of September 23, 2025, and the product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $1,215.11 to AmerisourceBergen Drug Corp for Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packages of six on August 11, 2025. This firm fixed price delivery order, which is expected to be completed by August 12, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packages of three, with a ceiling value of $4,829.14. The award was made on September 23, 2025, with an ultimate completion date of September 24, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $18,142.31 delivery order to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 2.5 mg tablets in unit dose packages of 6, with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and represents a routine pharmaceutical procurement supporting federal healthcare operations. The contract is executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.66 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg tablets (3-packs). The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, and carries a firm fixed price structure with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $337 delivery order to Amerisourcebergen Drug Corporation for 2.5 mg doses of Zolmitriptan orally disintegrating tablets. As the prime contractor, Amerisourcebergen will deliver the medication to a Defense Logistics Agency facility located in Conshohocken, Pennsylvania within the period of performance between September 11-12, 2023. The firm fixed price contract was awarded utilizing Amerisourcebergen's position on an existing DLA pharmaceuticals contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,425.20 contract is for the supply of zolmitriptan 2.5 mg orally disintegrating tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,621.40 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,566,407,890 zolmitriptan 5 mg tablets. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB26FVGSCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging. This competitive award, valued at $1,613.03 with a firm fixed price structure, represents a single delivery order without set-aside designation. The contract is scheduled for completion on October 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. Zolmitriptan, a migraine treatment medication, falls within the neurological pharmaceuticals category covered under the firm's extensive portfolio of federal medical supply contracts. This delivery order exemplifies the recurring, competitively awarded transactions through which AmerisourceBergen fulfills critical pharmaceutical needs for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/21/25 |